The Daily Papule

Wednesday 7 October

Derm Ther
Does Baseline Severity of Atopic Dermatitis Impact the Long-Term Efficacy of Abrocitinib? Post-hoc Analysis of Two Randomized Trials.
Pink AE, Rice ZP, … senior author Watkins MDermatology and Therapy
Read at publisher(opens in a new tab)
Acta DVObservational study
Efficacy and Safety of Delgocitinib and Its Impact on Patient's Perspective for Moderate-to-severe Chronic Hand Eczema in Adults
A 16-week Real-world Prospective Multicentre Study.
Pezzolo E, Luyo Saboya RA, … senior author Rossi MActa Dermato-Venereologica
Read at publisher(opens in a new tab)
J Derm TreatMeta-analysisSystematic review
Randomized evidence breadth and comparative maturity of systemic targeted therapies for prurigo nodularis
a time-aligned systematic review and network meta-analysis.
Liu Y, Hu H, Li LJournal of Dermatological Treatment
Read at publisher(opens in a new tab)

Tuesday 6 October

IJDMeta-analysisSystematic reviewLetter
Prevalence and Association of Psychiatric Comorbidities in Prurigo Nodularis
A Systematic Review and Meta-Analysis.
Chalupczak N, Mense S, … senior author Chovatiya RInternational Journal of Dermatology
No abstractRead at publisher(opens in a new tab)
Arch Derm ResObservational study
Association between prurigo nodularis and skin cancer
a propensity score–matched cohort study using the all of us research program
K Joe M, Husseinali M, A Wasko CArchives of Dermatological Research
No abstractRead at publisher(opens in a new tab)
JAAD Int
Plasma biomarker profiling suggests renal stress and systemic inflammation in chronic pruritus of unknown origin.
Vats K, Wilmer J, … senior author Kwatra SGJAAD International
No abstractRead at publisher(opens in a new tab)
J Dermatol
Non-Pharmacological Psychosomatic Approaches to Patients With Atopic Dermatitis
A Delphi Consensus of Expert Opinions in Japan.
Minami-Hori M, Hasuo H, … senior author Sudo NJournal of Dermatology
Read at publisher(opens in a new tab)

Monday 5 October

JID
IL-13-Amphiregulin pathway exacerbates itch in allergic contact dermatitis.
Dai X, Yan X, … senior author Meng JJournal of Investigative Dermatology
No abstractRead at publisher(opens in a new tab)

Saturday 3 October

Arch Derm ResObservational study
Differences in clinical characteristics and lifestyle factors between black and white patients with prurigo nodularis patients: a cross-sectional analysis
Pathak GN, Akiska YM, … senior author Kwatra SGArchives of Dermatological Research
No abstractRead at publisher(opens in a new tab)

Friday 2 October

Derm TherObservational study
D-CARE (Delgocitinib-Chronic hAnd Eczema Response Evaluation)
A Retrospective, Multicenter, Real-World Study of Patients with Chronic Hand Eczema (CHE) Treated with Delgocitinib 2% Cream-Temporal Analysis of Symptom and Clinical Sign Response.
Napolitano M, Turco M, … senior author Patruno CDermatology and Therapy
Read at publisher(opens in a new tab)

Thursday 1 October

JEADVReview
Systemic pruritus as a neuroimmune disorder
Mechanistic insights and target-driven therapy.
Reinhart S, Marijn S, … senior author Jo LJournal of the European Academy of Dermatology and Venereology
Read at publisher(opens in a new tab)
JAAD
Bullous Pemphigoid.
Sagut P, Balan K, Elston DMJournal of the American Academy of Dermatology
No abstractRead at publisher(opens in a new tab)

Wednesday 30 September

JCMSLetter
Exclusion of Psychiatric Comorbidities in Prurigo Nodularis Randomized Controlled Trials.
Levy R, Perlmutter JW, … senior author Dytoc MJournal of Cutaneous Medicine and Surgery
No abstractRead at publisher(opens in a new tab)

Friday 25 September

BJDClinical trial
Efficacy and Safety of Risankizumab in Paediatric Patients With Psoriasis in the OptIMMize-1 Phase III Study.
Magnolo N, Lara WL, … senior author Paller ASBritish Journal of Dermatology
Read at publisher(opens in a new tab)

Wednesday 23 September

JAMA DermRCT
Efficacy and Safety of Ruxolitinib Cream in Patients With Cutaneous Lichen Planus
A Randomized Clinical Trial.
Mangold AR, Lockshin B, … senior author Ehst BDJAMA Dermatology
Read at publisher(opens in a new tab)

Tuesday 22 September

Derm TherClinical trial
Development of a Conceptual Disease Model of Atopic Dermatitis Using Data from the Phase 3 ARCADIA 1 Trial.
Silverberg JI, Daniele P, … senior author Puelles JDermatology and Therapy
Read at publisher(opens in a new tab)
JID
The itch-dominant phenotype of atopic dermatitis carries a disproportionate psychosocial burden.
Misery L, Seneschal J, … senior author Richard MAJournal of Investigative Dermatology
No abstractRead at publisher(opens in a new tab)

Sunday 20 September

Arch Derm Res
Evaluation of Itch severity and automatic thoughts in patients with Lichen Simplex Chronicus and Chronic Idiopathic Pruritus: a preliminary report
Kara YA, Kapucu BBArchives of Dermatological Research
No abstractRead at publisher(opens in a new tab)

Thursday 17 September

Arch Derm Res
Erectile dysfunction in patients with prurigo nodularis in the all of us research program
Khodadad K, Rabbin-Birnbaum C, … senior author Zampella JGArchives of Dermatological Research
No abstractRead at publisher(opens in a new tab)
JDDGLetter
Pruritus and Psychiatric Distress in SLC20A2-Associated PFBC: A Dual-Specialty Perspective.
Lima E, Oliveira JRMJournal der Deutschen Dermatologischen Gesellschaft
No abstractRead at publisher(opens in a new tab)

Journals and topics

Itch & prurigo

Wednesday 7 October

Does Baseline Severity of Atopic Dermatitis Impact the Long-Term Efficacy of Abrocitinib? Post-hoc Analysis of Two Randomized Trials.

Efficacy and Safety of Delgocitinib and Its Impact on Patient's Perspective for Moderate-to-severe Chronic Hand Eczema in Adults

Randomized evidence breadth and comparative maturity of systemic targeted therapies for prurigo nodularis

Tuesday 6 October

Prevalence and Association of Psychiatric Comorbidities in Prurigo Nodularis

Association between prurigo nodularis and skin cancer

Plasma biomarker profiling suggests renal stress and systemic inflammation in chronic pruritus of unknown origin.

Non-Pharmacological Psychosomatic Approaches to Patients With Atopic Dermatitis

Monday 5 October

IL-13-Amphiregulin pathway exacerbates itch in allergic contact dermatitis.

Saturday 3 October

Differences in clinical characteristics and lifestyle factors between black and white patients with prurigo nodularis patients: a cross-sectional analysis

Friday 2 October

D-CARE (Delgocitinib-Chronic hAnd Eczema Response Evaluation)

Thursday 1 October

Systemic pruritus as a neuroimmune disorder

Bullous Pemphigoid.

Wednesday 30 September

Exclusion of Psychiatric Comorbidities in Prurigo Nodularis Randomized Controlled Trials.

Friday 25 September

Efficacy and Safety of Risankizumab in Paediatric Patients With Psoriasis in the OptIMMize-1 Phase III Study.

Wednesday 23 September

Efficacy and Safety of Ruxolitinib Cream in Patients With Cutaneous Lichen Planus

Tuesday 22 September

Development of a Conceptual Disease Model of Atopic Dermatitis Using Data from the Phase 3 ARCADIA 1 Trial.

The itch-dominant phenotype of atopic dermatitis carries a disproportionate psychosocial burden.

Sunday 20 September

Evaluation of Itch severity and automatic thoughts in patients with Lichen Simplex Chronicus and Chronic Idiopathic Pruritus: a preliminary report

Thursday 17 September

Erectile dysfunction in patients with prurigo nodularis in the all of us research program

Pruritus and Psychiatric Distress in SLC20A2-Associated PFBC: A Dual-Specialty Perspective.